Problems viewing this newsletter? View it in your browser >

June 5, 2013

Dear Advocate,

This update provides resources related to the recent World Health Organization (WHO) prequalification of the PrePex device for non-surgical voluntary medical male circumcision (VMMC). AVAC will be hosting a webinar to learn about and discuss this development next Tuesday, June 11 at 10am US Eastern. Click here to register.

The announcement last week that the WHO prequalified the PrePex device for non-surgical medical male circumcision could help to pave the way for further expansion of VMMC programs in countries hard hit by the HIV epidemic. Non-surgical devices such as PrePex do not require sutures or injectable anesthesia, which are routine during surgical VMMC. As part of comprehensive HIV prevention programs, VMMC has already made an impact on the HIV epidemic in many communities and countries.

The impact of PrePex, and other non-surgical devices that could also be prequalified in the future, will depend on several factors including the cost of the devices, the quality and scope of data available to guide decisions about product introduction, and sustained investment in product introduction including pilot projects and social marketing. There is a range of issues that require attention from advocates, and we hope the resource list below will help spark discussion and action.

As advocates we must ensure that implementers and policy makers develop clear plans and communications around the pros and cons of PrePex in terms of acceptability, cost and logistics related to its introduction. Importantly, the recent WHO prequalification is for men 18 and older. There’s a need for data on the use of devices in younger men and adolescents.

WEBINAR – VMMC Non-Surgical Devices: WHO pre-qualification and beyond
For more on translating prequalification into practice, join AVAC’s global advocates’ webinar featuring policy makers, funders and implementers involved in non-surgical devices on Tuesday, June 11 at 10am US Eastern / 4pm Johannesburg / 5pm Nairobi.

Register here.

For more on VMMC advocacy, see Call to Action on VMMC that AVAC published last year with NEPHAK, Sonke Gender Justice and UNASO and the VMMC-related priority from AVAC Report 2012. For a wide range of information on VMMC research and rollout visit

As always, please let us know if you have any questions.


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423